Eli Kjøbli

Statistics

Publications

Citations

337

H-Index

Active since

2006

Affiliations

Norwegian University of Science and Technology(Current)

St Olav's University Hospital

Eli Kjøbli is an author at Norwegian University of Science and Technology specializing in egfr inhibition, cancer pharmacology, and tyrosine kinase inhibitors.

Publications per year

2006–2017

Publications

Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism

Liv Thommesen, Astrid Kamilla Stunes, Marta Monjo et al. · Journal of Cellular Biochemistry · 2006 · 206 citations

Medicine, Molecular Biology, Physiology +11

N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2

Jennifer Mildenberger, Ida Johansson, Ismail Sergin et al. · Autophagy · 2017 · 55 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Synthesis and in vitro EGFR (ErbB1) tyrosine kinase inhibitory activity of 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines

Svein Jacob Kaspersen, Christopher Sørum, Veronica Willassen et al. · European Journal of Medicinal Chemistry · 2011 · 37 citations · Full text

Medicine, Medicinal Chemistry, Oncology +11

Identification of new 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines as highly potent EGFR-TK inhibitors with Src-family activity

Svein Jacob Kaspersen, Jin Han, Kristin G. Nørsett et al. · European Journal of Pharmaceutical Sciences · 2014 · 29 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

The Scandinavian Small-for-Gestational Age (SGA) pregnancy and birth cohort – A source to continual insight into fetal growth restriction and long term physical and neurodevelopmental health in mother and offspring

Eli Kjøbli, Ragnhild Bach, Haakon Skogseth et al. · Norsk Epidemiologi · 2016 · 10 citations · Full text

Public Health, Maternal Health, Obstetrics +17

1–5 of 5